{"name":"Yi Zhang","slug":"yi-zhang","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-26","type":"pipeline","source":"South China Morning Post","summary":"Chinese nationals, firms charged in US with smuggling AI chips, drug trafficking - South China Morning Post","headline":"Chinese nationals, firms charged in US with smuggling AI chips, drug trafficking","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOdE0zcjJzOWdHbHVKLTFwM0JRejZLRXZ6R2s4dDNkUFFCWGwyRS1HZWJMbHlTWFVVTi1MbEdGcjhZT1plbTVMbmxxMGZRcjBycjN0NE1GZWhrMUNacE5XM1VQSUZ1SUk3THRfcFpRVjNhRjZ6WG5uMng3OVNwNkExRjJZUzNyMU1fRXdWSVVCWU5ZYTJ5RGF6SDU1a05MX0R5cU9FMktTcDVnY21lWW5xeHhGVk4zSUk?oc=5","date":"2026-03-25","type":"pipeline","source":"Blockonomi","summary":"FBI Charges Six Chinese Nationals, Two Pharma Companies in Major Fentanyl Precursor Crackdown - Blockonomi","headline":"FBI Charges Six Chinese Nationals, Two Pharma Companies in Major Fentanyl Precursor Crackdown","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-24","type":"pipeline","source":"Fox News","summary":"FBI’s ‘Operation Box Cutter’ indicts Chinese pharma firms, terror-linked cartel assets in fentanyl takedown - Fox News","headline":"FBI’s ‘Operation Box Cutter’ indicts Chinese pharma firms, terror-linked cartel assets in fentanyl takedown","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA2cVpseEUtUUJmOTRPcEFsbjB5Ty1DR2Joc0QybVJIRUR4VXVOblBUMEFQOGV5X3R5aFVlbVRaajZZOXhLZUFfcXdnWHlrTDdZTzV0Vk1hWjVJN2FNLU93?oc=5","date":"2026-02-20","type":"pipeline","source":"nature.com","summary":"A small molecule inhibitor of ARF GTPase protein 1 limits liver and colon cancer cell growth and metastasis - nature.com","headline":"A small molecule inhibitor of ARF GTPase protein 1 limits liver and colon cancer cell growth and metastasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNN3BfeTNMZUpaTmxBMDN4WGRPSmt4elpOTVVvRDZ1Rm94VEdKX2FJR1l3ZVl1NzNnZnFoWnpDNTVHU1hkOU9rY3c2Qlp4MWtLN3R6RVM1a3hzVElobnlnV0Q0YTBJS0dJV2d5aVN3MGViN1Y0QzRuMWVLVkZ0M3RoaHRGUU9zak5wQmNDSi1OV2FwVFlOcXNBamtzZ19sRkVUWGNDX0Y0eTBzQQ?oc=5","date":"2025-12-31","type":"pipeline","source":"Sixth Tone","summary":"China Takes a Shot at Pet Obesity — Using Weight-Loss Drugs - Sixth Tone","headline":"China Takes a Shot at Pet Obesity — Using Weight-Loss Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPOVJWdTZKaWcxOXZJbXFsdGlLSFpOTkFmcXBEUVU0TTNpbkE3V09KOEVQUkhUSGRidXlMbkxBa2M4YVVid1pyYVBibGVoN2hMbExvdktmaTBsMHpoUTE0ZmgzZ01BUWItMzFRQlZxeEUwQlNCMllWWWNQR3d2ejUxN2l2ZjZhNHBMZmdn?oc=5","date":"2025-09-30","type":"trial","source":"The Lancet","summary":"Challenges for Chinese innovative cancer drugs in going global: insights from multiregional clinical trials - The Lancet","headline":"Challenges for Chinese innovative cancer drugs in going global: insights from multiregional clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNRVhTeUZvczRjZXkyaHl0X3FHak5HaUtFT29LeURLc3VoNDJ1Nmo4M3lqTVlxMWFKVndMVm9ia1U2UFBkbW9vRWhFekZIMDZDYS0tdFRuVGdfR1BsT3htM1RBUWdDTVR1cnRSUWxnUEtUUXp1bXJnT2FkejlJUkVCbFFfYWdJOUZsbXgyOFUyTFlzV0c0V3VBd09Eejk?oc=5","date":"2025-08-20","type":"pipeline","source":"Agency for Science, Technology and Research","summary":"Insights into LNP design for mRNA delivery - Agency for Science, Technology and Research","headline":"Insights into LNP design for mRNA delivery - Agency for Science, Technology and Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9MaC05ek5ycEJyMVZwanZHelhCQVdraFpRMHh1SmVCNDA4WVlRNk5IejIxZ1k2NFhnUjJEWFljMC1lRDU3azNERjREaGtfM0FrSUtJSnQxZUFpNno5OW12VHhDdmFOSmxSUUMycVU3dDdEcl9FVVhj?oc=5","date":"2024-12-14","type":"earnings","source":"Yicai Global","summary":"Baili Pharmaceutical passed the IPO filing: the revenue in the first 4 months was 5.5 billion, and Zhu Yi controlled 74% of the shares - Yicai Global","headline":"Baili Pharmaceutical passed the IPO filing: the revenue in the first 4 months was 5.5 billion, and Zhu Yi controlled 74%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxOLVNYSFJQRVp0U2FRWE1lXy1kVVdDMWdKWEFzdGN3bl9PWDBTaVBacnRTQVNNNUdEUFVyOFgzbU43MVpFRkhKQldlSUs0Q2lkcGhSbjBSZG5ldDJyWEZkc2ZtSS1kVG9hZnhfSmZzdHhVV1pibTZ5dVBFdHNReTUzTU9pVzhMSkpxTGkwYlJwTFFrc0FZZno1b3had01VSHViUGlwN3VCVmF5RDluTm9FdnJweHg2VS1RRWxmR2tBUFJOUE9ZOUtQTXVYczZaOUNZNERCeXRGOGVoN3dDQXgyTzlETUZtblZrNUJpVjR1cVl4QjFmcVpLNDFoakRCYl9XaXlNU3JrQQ?oc=5","date":"2024-12-12","type":"pipeline","source":"GlobeNewswire","summary":"LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China - GlobeNewswire","headline":"LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFBoaTlDNjROZHVIemVISXF1NGgyVHJFUy1CLUJ4Zk9hcEZsZXdiUnVhdXJ4bU55VklTVEsxcjlmRlJSZzFJdEVBY0VlWGFZVjM1QW5RY2RfYjFRNHMxSzRDSDh3?oc=5","date":"2024-11-09","type":"pipeline","source":"ACS Publications","summary":"Bioorthogonal Chemistry-Guided Inhalable Nanoprodrug to Circumvent Cisplatin Resistance in Orthotopic Nonsmall Cell Lung Cancer - ACS Publications","headline":"Bioorthogonal Chemistry-Guided Inhalable Nanoprodrug to Circumvent Cisplatin Resistance in Orthotopic Nonsmall Cell Lung","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFB3clRyWm5oUmk4Zk1qU2dMaDU0bjNwN3pQaHBOVndLQUMydUFodjAtVDZwN3VEbzFUbzA0OXhOMFpXb3lEWVY1M2Z6a24xaWEwVVpiUWFCeU1TXzhfQnk2M3BvOTZGUmFsNnVOUW51d0JJM2tCbnFOcVUzZUpOUQ?oc=5","date":"2023-09-05","type":"pipeline","source":"Massachusetts General Hospital","summary":"Anesthesia Spotlight: Yi Zhang, MD, PhD - Massachusetts General Hospital","headline":"Anesthesia Spotlight: Yi Zhang, MD, PhD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5IQkpJbEdjZDBYY3RLb2FudzU1RnE2TFBIS2drdUpBUlV3dlJKRG5JSWt4bWxnV2VlMjdKeVZYTzIxVVpHVDJrVUtHc01aVlB1cGpWWmVwVWdacTY2MWMxaE1jeUxTQ1lMSWc?oc=5","date":"2023-07-20","type":"trial","source":"Wiley Online Library","summary":"Oral azvudine for mild-to-moderate COVID-19 in high risk, nonhospitalized adults: Results of a real-world study - Wiley Online Library","headline":"Oral azvudine for mild-to-moderate COVID-19 in high risk, nonhospitalized adults: Results of a real-world study","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}